FindTrial
Sign In

prospective observational study for evaluating Efficacy and safety of Megaderm applied in autologous flap defect site in Breast reconstruction patient with conjoined fascial flap

prospective observational study for evaluating Efficacy and safety of Megaderm applied in autologous flap defect site in Breast reconstruction patient with conjoined fascial flap

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
CRIS
Registry ID
KCT0007650
Enrollment
20
Registered
2022-08-09
Start date
2022-09-01
Completion date
Unknown
Last updated
2022-09-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

None listed

Sponsors

Kyungpook National University Medical Center
Lead Sponsor

Eligibility

Sex/Gender
Female

Inclusion criteria

Inclusion criteria: ? over 19 years of age ? Those patients who had undergone breast reconstruction with autologous flap after mastectomy due to breast cancer ? In case of ADM(megaderm) applied in a breast reconstruction surgery

Exclusion criteria

Exclusion criteria: ? current smoker (over one cigarette in a day) ? patients confirmed whole body metastasis of breast cancer ? who will be get a radiation therapy after surgery ? who have been Angina pectoris, COPD, diabetes, renal failure, metabolic disease or any of history ? pregnant or lactating women

Design outcomes

Primary

MeasureTime frame
Aesthetic outcome;Evaluation of the frequency and rate of complication—

Secondary

MeasureTime frame
Evaluation of satisfaction—

Countries

Korea, Republic of

Contacts

Public ContactJoon Seok Lee

Kyungpook National University

leejspo@knu.ac.kr+82-53-200-5685

Outcome results

None listed

Source: CRIS (via WHO ICTRP) · Data processed: Feb 4, 2026